wp-plugin-hostgator
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home4/scienrds/scienceandnerds/wp-includes/functions.php on line 6114ol-scrapes
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home4/scienrds/scienceandnerds/wp-includes/functions.php on line 6114Source: https:\/\/www.theverge.com\/2022\/8\/11\/23301923\/adhd-telehealth-opioid-use-disorder-treatment-pandemic<\/a> Pandemic-era rules around telemedicine have been a huge boost to efforts to prevent opioid overdoses in the US. But those rules are also how controversial startup<\/a> companies like Cerebral were able to prescribe Adderall and Xanax to huge numbers of people \u2014 and efforts to stem that flood of prescriptions could sweep away overdose prevention efforts in the process. <\/p>\n Since 2020, doctors have been able to prescribe controlled substances after a telehealth visit without needing to see patients in person. But that\u2019s a big umbrella: Adderall and Xanax are controlled substances. So are buprenorphine and methadone, which are used to treat people dependent on opioids. Opioid overdoses have reached epidemic proportions in the US, with tens of thousands of people dying every year. <\/p>\n Telehealth led to clear improvements in treatment access for people with opioid addiction or dependence<\/a>, also known as opioid-use disorder. But the policies that led to those improvements aren\u2019t guaranteed to stay in place. They could end, and the risk of them ending went up with the public backlash to practices of companies like Cerebral, which used those same telehealth policies to distribute huge numbers of prescriptions \u2014 including medications that are often misused. The COVID-19 public health emergency that enabled both is set to expire in October<\/a>, though the Biden administration could extend it<\/a> again. But it will end eventually, and when it does, policymakers will have to decide if they\u2019re going to keep some of the relaxed public health rules or if they\u2019ll revert to the pre-pandemic status quo. <\/p>\n
\n
<\/br><\/code><\/p>\n